By Rafel Solamis
Quantar Core (TRI-FP) - In a surprise move, competitors Cromforge Enterprises and Tens & Piney have announced a deal that they claim will herald the end of the conflict between their corporations, and allow them to focus on producing the cure for the Letifer Virus.
While the details of the agreement have not been made public, insiders claim that Tens & Piney has agreed to transfer all their unused acquired materials to Cromforge, which will enable Cromforge to complete their bid for the rights to the cure being developed by Samsun Universal. In return, sources indicate that Tens & Piney will be granted the exclusive rights to resell the cure outside of Quantar space.
"Given recent events, especially the betrayal of Tens & Piney by squad -=DragonEye=-, this deal is in the best interests of our major investors," remarked Vivian Duvazaco, for Tens & Piney. "By accelerating Cromforge's efforts to successfully complete their bid, and thus accelerating delivery of the cure to Perasca, Tens & Piney can once more focus on our key business activities of increasing our value to our shareholders."
"The agreement is clearly the best solution for everyone involved, especially those on Perasca who are suffering from the virus," stated Cila Rotup'uh for Cromforge. "By combining and focusing our efforts, we can better work with Samsun to ensure the cure gets to those who need it as fast as possible. We have also initiated discussions with Paqu Imusena for assistance in distributing the cure, once the final agreements with Samsun are in place, and the specifications and manufacturing facilities for the cure are made available."
Requests for comment from Samsun Universal were not immediately returned.
Link To JOSSH Article